MÊME is a dermo-cosmetic brand that specifically caters to individuals undergoing cancer treatments. Launched in 2017 by Judith and Juliette, who experienced cancer with their loved ones, the brand aims to provide effective, safe, and sensorial skincare solutions without compromising on quality. MÊME's product line is natural, safe, and inclusive, tailored for sensitive skin and nails. It is available for purchase on their e-shop and in over 5,000 pharmacies and parapharmacies, embodying an empathetic and high-standard approach to beauty.
Having received a Series A investment on 14th February 2018 from Otium Capital, MÊME operates in the industries of design, fashion, healthcare, wellness beauty, and lifestyle. With its headquarters in France, MÊME's dedication to addressing a specific, yet critical, segment of the skincare market presents a promising investment opportunity in the beauty and wellness sector.